Pfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs

By Francesca Fontana

Pfizer Inc. (PFE) and Johnson & Johnson (JNJ) are trading at the bottom of the Dow Jones Industrial Average Thursday, weighing on exchange-traded funds with high exposure to the pharmaceutical stocks.

Pfizer ranks among the top ten holdings at 21.2% in BlackRock's iShares U.S. Pharmaceuticals ETF (IHE), according to ETF.com. IHE tracks a broad-based, cap-weighted index of U.S. pharmaceutical companies. Its other top holdings include Johnson & Johnson, Elanco Animal Health Inc., and Allergan PLC.

IHE is trading lower during Thursday's session, falling 0.6%.

Johnson & Johnson ranks among the top ten holdings at 9.7% in BlackRock's iShares Evolved U.S. Innovative Healthcare ETF (IEIH). Per ETF.com, IEIH tracks an index that offers U.S. pharmaceutical and biotechnology exposure. Its other top holdings include Pfizer, Merck & Co., Celgene Corp., and Eli Lilly & Co.

IEIH is trading lower, losing 0.9%.

Pfizer and Johnson & Johnson continue to lose ground as investors weigh the impact of legislative proposals such as Medicare for All. Pfizer shares fall 1.6% to $39.26, and Johnson & Johnson shares fall 1.1% to $137.01.

(END) Dow Jones Newswires

April 18, 2019 15:21 ET (19:21 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.